论文部分内容阅读
目的观察联用参附注射液与低分子肝素治疗重症肺心病心力衰竭的疗效。方法将100例患者随机分为两组均给予常规综合治疗。治疗组联用参附注射液与低分子肝素。结果治疗组治疗后各项观察指标明显好转,与本组治疗前及对照组治疗后比较差异有统计学意义(P<0.05或P<0.01)。结论联用参附注射液与低分子肝素治疗重症肺心病心力衰竭疗效显著,在临床有广泛应用价值。
Objective To observe the curative effect of Shenfu injection and low molecular weight heparin on heart failure of patients with severe cor pulmonale. Methods 100 patients were randomly divided into two groups were given conventional comprehensive treatment. Treatment group with Shenfu injection and low molecular weight heparin. Results After treatment, the observation indexes of the treatment group improved significantly, which were significantly different from those of the control group before and after treatment (P <0.05 or P <0.01). Conclusion Shenfu injection and low molecular weight heparin are effective in treating heart failure due to severe pulmonary heart disease and have a wide range of clinical value.